Data imputation [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2020-07-02 11:15 (471 d 11:56 ago) – Posting: # 21635
Views: 2,892

Hi Martin,

» […] adequate handling would require some modeling which seems to be in contradiction to regulatory thinking as NCA is clearly favored in BA/BE studies.

Yep. The EMA’s BE-GL states:

Non-compartmental methods should be used for determination of pharmacokinetic parameters in bioequivalence studies. The use of compartmental methods for the estimation of parameters is not acceptable.


» However, I would like to bring a recent paper on this topic to your attention: […]

Why am I not surprised that Thomas recommends kernel density imputation? ;-)
However, PK modeling is not applied. \(\small{\widehat{AUC}}\) is still obtained by NCA, right?

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,729 posts in 4,543 threads, 1,543 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Saturday 23:12 CEST (Europe/Vienna)

If you want to converse with me,
define your terms.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5